Skip to content
healthcare.dev

Fluticasone Furoate and Vilanterol

NDC 66993-135, fluticasone furoate and vilanterol, powder, from Prasco Laboratories.

Product NDC
66993-135
Status
Listed
Labeler
Prasco Laboratories
Dosage form
POWDER
Route
RESPIRATORY (INHALATION)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA204275
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66993-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FLUTICASONE FUROATE100 ug/1
  • VILANTEROL TRIFENATATE25 ug/1

Pharmacologic classes

Adrenergic beta2-Agonists [MoA]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; beta2-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
66993-135-97669930135971 TRAY in 1 CARTON (66993-135-97) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3a761487-c300-451a-8537-3196c00c11b5
  • NADAC price for package 66993013597

    GET /v1/drugs/nadac/66993013597

Use it

Look up 66993-135 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66993-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66993-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.